Diaphragm-sparing Nerve Blocks for Shoulder Arthroplasty
NCT ID: NCT03877835
Last Updated: 2021-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2019-03-18
2020-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Diaphragm-Sparing Nerve Block for Arthroscopic Shoulder Surgery?
NCT03195426
A Novel Combination of Peripheral Nerve Blocks for Patients Scheduled for Shoulder Surgery
NCT02809144
Comparison of Pulmonary Function and Efficacy of Different Nerve Block Catheters for Shoulder Surgery
NCT02117778
Comparison of the Interscalene Block Alone Versus Combined With Superior Truncus Block During Shoulder Surgery in Diaphragmatic Function
NCT07338630
Interscalene Block Versus Costoclavicular Block for Shoulder Surgery
NCT03411343
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary aims of this study were to document numeric rating scale (NRS, 0-10) and use of morphine equivalents during the first 24 hours after surgery. Secondary aims were to determine the incidence of diaphragm paresis 30 minutes after the block and to quantify postoperative hand grip force at 1 hr.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ropivacaine
SSNB will be performed with 4 ml ropivacaine 5 mg/ml LSIB will be performed With 15 ml ropivacaine 7.5 mg/ml
Peripheral nerve blocks
LSIB + SSNB
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peripheral nerve blocks
LSIB + SSNB
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 20-35 kg.m-2
* ASA physical status 1-3
Exclusion Criteria
* pregnancy,
* pre-existing severe respiratory disease,
* use of anticoagulation drugs other than acetylsalicylic acid or dipyridamol,
* allergy to local anaesthetics,
* patients on regular opioids,
* atrioventricular block,
* peripheral neuropathy.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nordlandssykehuset Bodo
UNKNOWN
University Hospital of North Norway
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of North Norway
Tromsø, Troms, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REK 2018/1934-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.